Clinical Trials · NCT01642914
Safety and Efficacy of Linaclotide in Patients With Chronic Constipation and Prominent Abdominal Bloating
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Forest Laboratories
- Enrollment
- 487
- Start date
- Aug 2012
- Locations
- 151 sites, United States, Canada
- Primary endpoint
- 9/12 Week Complete Spontaneous Bowel Movement (CSBM) 3+1 Responder